Clinical Trial Update: Aprotinin in Neonates Undergoing Cardiopulmonary Bypass

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating aprotinin to reduce bleeding in neonates with congenital heart defects undergoing cardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Trasylol (aprotinin)

Snippet

Sponsor: Children's Healthcare of Atlanta | Conditions: Cardiopulmonary Bypass, Congenital Defects | Status: COMPLETED